We Are Here’s ability to launch, learn, and immediately apply those learnings to their next pilot demonstrates the kind of agile, data-driven approach that healthcare systems need from their technology partners. We Are Here just made CancerX history—we are the first startup to launch a pilot program before the cohort even ended! Our platform is transforming connections between social workers …
In the latest episode of the VisibleOps Podcast, Carolyn Treviño Jenkins, CEO and Co-Founder of We Are Here, joins Scott Alldridge, CEO of Figure Eight, to explore the deep connection between cybersecurity, culture, and operational trust. Hosted by Joe Young, the conversation highlights how purpose-driven organizations like We Are Here are navigating the complexities of digital trust—especially in healthcare. Carolyn …
Author: Carol Wang, Ph.D., Director of Clinical Research, We Are Here Clinical trials are crucial for many patients, by providing access to cutting-edge treatments and playing an important role in advancing medicine. However, many patients – especially those from underserved communities- face obstacles that limit their ability to participate. Common barriers include logistical challenges, financial concerns, and a lack of information …
FOR IMMEDIATE RELEASE CancerX Launches 2025 Accelerator to Drive Innovation in Oncology Chosen startups focus on enhancing access to treatment, speeding up clinical trials, and providing personalized care Nashville, Tenn. (Feb. 17, 2025) – CancerX, a public-private partnership designed to accelerate innovation in the fight against cancer, announced today the launch of its 2025 Accelerator cohort, featuring an incredible group …
Author: Carol Wang, Ph.D., Director of Clinical Research, We Are Here Cancer patients face significant financial challenges, especially when participating in clinical trials. Financial toxicity, the economic burden caused by cancer treatment costs, impacts patients’ ability to engage in trials that offer cutting-edge therapies. Despite the promise clinical trials hold for advancing cancer care, financial barriers—such as out-of-pocket costs, employment disruptions, …
